{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:35:10Z","timestamp":1790012110529,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Guangdong Basic and Applied Basic Research Foundation","award":["2023A1515010183"],"award-info":[{"award-number":["2023A1515010183"]}]},{"name":"the Natural Science Foundation of Shenzhen","award":["JCYJ20230807152759003"],"award-info":[{"award-number":["JCYJ20230807152759003"]}]},{"name":"the Research Project of Futian District Health System","award":["FTWS2023076"],"award-info":[{"award-number":["FTWS2023076"]}]},{"name":"the Startup Fund for Young Researchers of Sun Yat-sen University","award":["51000-12255003"],"award-info":[{"award-number":["51000-12255003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49973-3","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T09:53:31Z","timestamp":1777715611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surrogate virus neutralization test as a scalable and reliable tool for immune surveillance in booster-vaccinated populations"],"prefix":"10.1038","volume":"16","author":[{"given":"Lin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyun","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"49973_CR1","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/s0140-6736(24)00850-x","volume":"403","author":"AJ Shattock","year":"2024","unstructured":"Shattock, A. J. et al. Contribution of vaccination to improved survival and health: Modelling 50 years of the Expanded Programme on Immunization. Lancet 403, 2307\u20132316. https:\/\/doi.org\/10.1016\/s0140-6736(24)00850-x (2024).","journal-title":"Lancet"},{"key":"49973_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","volume":"21","author":"AJ Pollard","year":"2021","unstructured":"Pollard, A. J. & Bijker, E. M. A guide to vaccinology: From basic principles to new developments. Nat. Rev. Immunol. 21, 83\u2013100. https:\/\/doi.org\/10.1038\/s41577-020-00479-7 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"49973_CR3","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMsa2514268","volume":"393","author":"J Scott","year":"2025","unstructured":"Scott, J. et al. Updated evidence for Covid-19, RSV, and influenza vaccines for 2025\u20132026. N. Engl. J. Med. 393, 2221\u20132242. https:\/\/doi.org\/10.1056\/NEJMsa2514268 (2025).","journal-title":"N. Engl. J. Med."},{"key":"49973_CR4","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1056\/NEJMoa2510226","volume":"393","author":"M Cai","year":"2025","unstructured":"Cai, M., Xie, Y. & Al-Aly, Z. Association of 2024-2025 Covid-19 vaccine with Covid-19 outcomes in U.S. veterans. N. Engl. J. Med. 393, 1612\u20131623. https:\/\/doi.org\/10.1056\/NEJMoa2510226 (2025).","journal-title":"N. Engl. J. Med."},{"key":"49973_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/s0140-6736(22)00152-0","volume":"399","author":"DR Feikin","year":"2022","unstructured":"Feikin, D. R. et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: Results of a systematic review and meta-regression. Lancet 399, 924\u2013944. https:\/\/doi.org\/10.1016\/s0140-6736(22)00152-0 (2022).","journal-title":"Lancet"},{"key":"49973_CR6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114583","volume":"385","author":"EG Levin","year":"2021","unstructured":"Levin, E. G. et al. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months. N. Engl. J. Med. 385, e84. https:\/\/doi.org\/10.1056\/NEJMoa2114583 (2021).","journal-title":"N. Engl. J. Med."},{"key":"49973_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","volume":"602","author":"D Planas","year":"2022","unstructured":"Planas, D. et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature 602, 671\u2013675. https:\/\/doi.org\/10.1038\/s41586-021-04389-z (2022).","journal-title":"Nature"},{"key":"49973_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-022-04399-5","volume":"602","author":"JM Carre\u00f1o","year":"2022","unstructured":"Carre\u00f1o, J. M. et al. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature 602, 682\u2013688. https:\/\/doi.org\/10.1038\/s41586-022-04399-5 (2022).","journal-title":"Nature"},{"key":"49973_CR9","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/s2666-5247(21)00267-6","volume":"3","author":"D Cromer","year":"2022","unstructured":"Cromer, D. et al. Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: A meta-analysis. Lancet Microb. 3, e52\u2013e61. https:\/\/doi.org\/10.1016\/s2666-5247(21)00267-6 (2022).","journal-title":"Lancet Microb."},{"key":"49973_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41591-022-01705-6","volume":"28","author":"E P\u00e9rez-Then","year":"2022","unstructured":"P\u00e9rez-Then, E. et al. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. Nat. Med. 28, 481\u2013485. https:\/\/doi.org\/10.1038\/s41591-022-01705-6 (2022).","journal-title":"Nat. Med."},{"key":"49973_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00482-21","volume":"60","author":"A Misra","year":"2022","unstructured":"Misra, A. & Theel, E. S. Immunity to SARS-CoV-2: What do we know and should we be testing for it?. J. Clin. Microbiol. 60, e0048221. https:\/\/doi.org\/10.1128\/jcm.00482-21 (2022).","journal-title":"J. Clin. Microbiol."},{"key":"49973_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2020.112752","volume":"172","author":"M Y\u00fcce","year":"2021","unstructured":"Y\u00fcce, M., Filiztekin, E. & \u00d6zkaya, K. G. COVID-19 diagnosis -A review of current methods. Biosen. Bioelectron. 172, 112752. https:\/\/doi.org\/10.1016\/j.bios.2020.112752 (2021).","journal-title":"Biosen. Bioelectron."},{"key":"49973_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20247-4","volume":"12","author":"EHY Lau","year":"2021","unstructured":"Lau, E. H. Y. et al. Neutralizing antibody titres in SARS-CoV-2 infections. Nat. Commun. 12, 63. https:\/\/doi.org\/10.1038\/s41467-020-20247-4 (2021).","journal-title":"Nat. Commun."},{"key":"49973_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","volume":"9","author":"J Nie","year":"2020","unstructured":"Nie, J. et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg. Microb. Infect. 9, 680\u2013686. https:\/\/doi.org\/10.1080\/22221751.2020.1743767 (2020).","journal-title":"Emerg. Microb. Infect."},{"key":"49973_CR15","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41587-020-0631-z","volume":"38","author":"CW Tan","year":"2020","unstructured":"Tan, C. W. et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction. Nat. Biotechnol. 38, 1073\u20131078. https:\/\/doi.org\/10.1038\/s41587-020-0631-z (2020).","journal-title":"Nat. Biotechnol."},{"key":"49973_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21317-x","volume":"12","author":"HT Zedan","year":"2022","unstructured":"Zedan, H. T. et al. Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies. Sci. Rep. 12, 19020. https:\/\/doi.org\/10.1038\/s41598-022-21317-x (2022).","journal-title":"Sci. Rep."},{"key":"49973_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01268-w","volume":"10","author":"RA Purcell","year":"2025","unstructured":"Purcell, R. A. et al. Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccination. NP. J. Vaccin. 10, 217. https:\/\/doi.org\/10.1038\/s41541-025-01268-w (2025).","journal-title":"NP. J. Vaccin."},{"key":"49973_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1455730","volume":"15","author":"X Han","year":"2024","unstructured":"Han, X. et al. A head-to-head comparison of humoral and cellular immune responses of five COVID-19 vaccines in adults in China. Front. Immunol. 15, 1455730. https:\/\/doi.org\/10.3389\/fimmu.2024.1455730 (2024).","journal-title":"Front. Immunol."},{"key":"49973_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ijid.2021.07.027","volume":"109","author":"N Irwin","year":"2021","unstructured":"Irwin, N. et al. Age significantly influences the sensitivity of SARS-CoV-2 rapid antibody assays. Int. J. Infect. Dis. 109, 304\u2013309. https:\/\/doi.org\/10.1016\/j.ijid.2021.07.027 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"49973_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0337","volume":"4","author":"R Vashisht","year":"2021","unstructured":"Vashisht, R. et al. Age- and sex-associated variations in the sensitivity of serological tests among individuals infected with SARS-CoV-2. JAMA Netw. Open 4, e210337. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0337 (2021).","journal-title":"JAMA Netw. Open"},{"key":"49973_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003868","volume":"18","author":"S Karuna","year":"2021","unstructured":"Karuna, S. et al. Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study. PLoS Med. 18, e1003868. https:\/\/doi.org\/10.1371\/journal.pmed.1003868 (2021).","journal-title":"PLoS Med."},{"key":"49973_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2022.114902","volume":"658","author":"MJ Devi","year":"2022","unstructured":"Devi, M. J., Gaffar, S. & Hartati, Y. W. A review post-vaccination SARS-CoV-2 serological test: Method and antibody titer response. Anal. Biochem. 658, 114902. https:\/\/doi.org\/10.1016\/j.ab.2022.114902 (2022).","journal-title":"Anal. Biochem."},{"key":"49973_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-31114-9","volume":"13","author":"OJ Kweon","year":"2023","unstructured":"Kweon, O. J. et al. Performance evaluation of newly developed surrogate virus neutralization tests for detecting neutralizing antibodies against SARS-CoV-2. Sci. Rep. 13, 4961. https:\/\/doi.org\/10.1038\/s41598-023-31114-9 (2023).","journal-title":"Sci. Rep."},{"key":"49973_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/biomethods\/bpae095","volume":"10","author":"L Nkinda","year":"2025","unstructured":"Nkinda, L. et al. Evaluation of a surrogate virus neutralization assay for detecting neutralizing antibodies against SARS-CoV-2 in an African population. Biol. Method. Protoc. 10, bpae095. https:\/\/doi.org\/10.1093\/biomethods\/bpae095 (2025).","journal-title":"Biol. Method. Protoc."},{"key":"49973_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/antib12020035","author":"T Vilibic-Cavlek","year":"2023","unstructured":"Vilibic-Cavlek, T. et al. Detection of SARS-CoV-2 antibodies: Comparison of enzyme immunoassay, surrogate neutralization and virus neutralization test. Antibodies https:\/\/doi.org\/10.3390\/antib12020035 (2023).","journal-title":"Antibodies"},{"key":"49973_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10040510","author":"J Tuells","year":"2022","unstructured":"Tuells, J. et al. Detection of neutralizing antibodies against SARS-CoV-2 post-vaccination in health care workers of a large tertiary hospital in Spain by using a rapid test LFIC and sVNT-ELISA. Vaccines https:\/\/doi.org\/10.3390\/vaccines10040510 (2022).","journal-title":"Vaccines"},{"key":"49973_CR27","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1111\/all.15271","volume":"77","author":"ZJ Cheng","year":"2022","unstructured":"Cheng, Z. J. et al. Humoral immune response of BBIBP COVID-19 vaccination before and after the booster immunization. Allergy 77, 2404\u20132414. https:\/\/doi.org\/10.1111\/all.15271 (2022).","journal-title":"Allergy"},{"key":"49973_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0291670","volume":"18","author":"T Takahashi","year":"2023","unstructured":"Takahashi, T. et al. Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination. PLoS ONE 18, e0291670. https:\/\/doi.org\/10.1371\/journal.pone.0291670 (2023).","journal-title":"PLoS ONE"},{"key":"49973_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10621-2","volume":"25","author":"I G\u00fczel","year":"2025","unstructured":"G\u00fczel, I. et al. Neutralizing and binding antibody dynamics following primary and booster COVID-19 vaccination among healthcare workers. BMC Infect. Dis. 25, 218. https:\/\/doi.org\/10.1186\/s12879-025-10621-2 (2025).","journal-title":"BMC Infect. Dis."},{"key":"49973_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17410","volume":"9","author":"L Dulipsingh","year":"2023","unstructured":"Dulipsingh, L. et al. Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects. Heliyon 9, e17410. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17410 (2023).","journal-title":"Heliyon"},{"key":"49973_CR31","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/clinchem\/hvaa336","volume":"67","author":"A Bal","year":"2021","unstructured":"Bal, A. et al. Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of patients with mild COVID-19: Clinical sensitivity, specificity, and association with virus neutralization test. Clin. Chem. 67, 742\u2013752. https:\/\/doi.org\/10.1093\/clinchem\/hvaa336 (2021).","journal-title":"Clin. Chem."},{"key":"49973_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11081496","author":"Y Kim","year":"2021","unstructured":"Kim, Y. et al. Quantitative SARS-CoV-2 spike antibody response in COVID-19 patients using three fully automated immunoassays and a surrogate virus neutralization test. Diagnostics (Basel) https:\/\/doi.org\/10.3390\/diagnostics11081496 (2021).","journal-title":"Diagnostics (Basel)"},{"key":"49973_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12081781","author":"N Suntronwong","year":"2022","unstructured":"Suntronwong, N. et al. Strong correlations between the binding antibodies against wild-type and neutralizing antibodies against Omicron BA.1 and BA.2 variants of SARS-CoV-2 in individuals following booster (third-dose) vaccination. Diagnostics (Basel) https:\/\/doi.org\/10.3390\/diagnostics12081781 (2022).","journal-title":"Diagnostics (Basel)"},{"key":"49973_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2021.114228","volume":"297","author":"J Mari\u00ebn","year":"2021","unstructured":"Mari\u00ebn, J. et al. Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2. J. Virol. Method. 297, 114228. https:\/\/doi.org\/10.1016\/j.jviromet.2021.114228 (2021).","journal-title":"J. Virol. Method."},{"key":"49973_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.abm3425","volume":"375","author":"PB Gilbert","year":"2022","unstructured":"Gilbert, P. B. et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science 375, 43\u201350. https:\/\/doi.org\/10.1126\/science.abm3425 (2022).","journal-title":"Science"},{"key":"49973_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914965","author":"E Santos da Silva","year":"2023","unstructured":"Santos da Silva, E. et al. Validation of a SARS-CoV-2 surrogate neutralization test detecting neutralizing antibodies against the major variants of concern. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms241914965 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"49973_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12010094","author":"DN Springer","year":"2024","unstructured":"Springer, D. N. et al. Measuring variant-specific neutralizing antibody profiles after bivalent SARS-CoV-2 vaccinations using a multivariant surrogate virus neutralization microarray. Vaccines (Basel) https:\/\/doi.org\/10.3390\/vaccines12010094 (2024).","journal-title":"Vaccines (Basel)"},{"key":"49973_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bbrc.2023.01.052","volume":"646","author":"MJ Ahn","year":"2023","unstructured":"Ahn, M. J. et al. Evaluation of a biotin-based surrogate virus neutralization test for detecting postvaccination antibodies against SARS-CoV-2 variants in sera. Biochem. Biophys. Res. Commun. 646, 8\u201318. https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.052 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"49973_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00430-023-00773-w","volume":"212","author":"ER Haycroft","year":"2023","unstructured":"Haycroft, E. R. et al. Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants. Med. Microbiol. Immunol. 212, 291\u2013305. https:\/\/doi.org\/10.1007\/s00430-023-00773-w (2023).","journal-title":"Med. Microbiol. Immunol."},{"key":"49973_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.172470","author":"KJ Selva","year":"2023","unstructured":"Selva, K. J. et al. Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.172470 (2023).","journal-title":"JCI Insight"},{"key":"49973_CR41","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/clinchem\/hvab283","volume":"68","author":"KL Lynch","year":"2022","unstructured":"Lynch, K. L., Zhou, S., Kaul, R., Walker, R. & Wu, A. H. Evaluation of neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination using a multiplexed surrogate virus neutralization test. Clin. Chem. 68, 702\u2013712. https:\/\/doi.org\/10.1093\/clinchem\/hvab283 (2022).","journal-title":"Clin. Chem."},{"key":"49973_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1039163","volume":"13","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. Simultaneous measurement of multiple variant-specific SARS-CoV-2 neutralizing antibodies with a multiplexed flow cytometric assay. Front. Immunol. 13, 1039163. https:\/\/doi.org\/10.3389\/fimmu.2022.1039163 (2022).","journal-title":"Front. Immunol."},{"key":"49973_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126960","volume":"54","author":"G Dowgier","year":"2025","unstructured":"Dowgier, G. et al. Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics. Vaccine 54, 126960. https:\/\/doi.org\/10.1016\/j.vaccine.2025.126960 (2025).","journal-title":"Vaccine"},{"key":"49973_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127657","volume":"63","author":"JYL Fu","year":"2025","unstructured":"Fu, J. Y. L. et al. Longitudinal dynamics of immune responses after mRNA and inactivated COVID-19 vaccination, boosters, and breakthrough infections in Malaysia. Vaccine 63, 127657. https:\/\/doi.org\/10.1016\/j.vaccine.2025.127657 (2025).","journal-title":"Vaccine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49973-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49973-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49973-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:05:23Z","timestamp":1783076723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49973-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49973"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49973-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"1 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the School of Public Health, Sun Yat-sen University, and the Ethics Committee of the Futian District Center for Disease Control and Prevention. All participants provided written informed consent before enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"20377"}}